2-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine, 97%, 100mg

1-Hydroxy-1h-1,2,3-benzotriazole-6-carboxylic acid, 95%, 50mg

3-bromo-6-chloro-2H-pyrazolo[4,3-c]pyridine, 97%, 1g

iScope IS.1153-PLi/DFi Triocular with Plan IOS objectives and Rackless cross stage (dark field contrast application)

Dicyclohexyl(1,1-diphenylprop-1-en-2-yl)phosphine, 98% mix TBC as stabilizer, 250mg

Palladium(II) Acetate Trimer>98.0%(T)5g

2',6'-Dichloro-3'-fluoroacetophenone, 98.0%, 100g

Ethyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)piperidine-3-carboxylate, 95.0%, 1g

5,7-Dichloro-3-ethylpyrazolo[1,5-a]pyrimidine, 95.0%, 1g

tert-Butyl 5-cyano-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 100mg

Sodium nitrite, min. 99%, cryst., 25 kg, plastic packaging.

1,4-Dibromophthalazine, 95%, 250mg

5-CHLORO-3,3-DIMETHYLISOINDOLIN-1-ONE, 95.0%, 250mg